Recently, the research group led by Dr. Dechao Feng, Lecturer at University College London (UCL) and Distinguished Research ...

Researchers at Moffitt Cancer Center report encouraging early results from a phase 2 study examining whether immunotherapy ...

In prostate cancer, hormone therapy is treatment to keep the cancer cells from getting testosterone, the main male hormone (androgen). Hormone therapy for prostate cancer is also called ...

Findings seen over three months in men with low-grade prostate cancer, hypogonadism treated with radical prostatectomy.

An investigator presented extended follow-up data from a phase 3 trial on aglatimagene besadenovec (CAN-2409) + prodrug in combination with standard-of-care EBRT in men with localized prostate cancer.

A new blood test could help doctors identify whether a treatment for advanced prostate cancer is failing weeks earlier than ...

Researchers with the James P. Allison Institute at The University of Texas MD Anderson Cancer Center have discovered a new ...

About 1 in 8 men will be diagnosed with prostate cancer in their lifetime The average age at diagnosis is 67 Less than 1% of the 3.5 million men living with prostate cancer are expected to die from it ...

A groundbreaking new study suggests that prostate cancer treatment may soon become faster, simpler, and less disruptive for ...

Metastatic prostate cancer is cancer that began in the prostate but has spread to other parts of the body. There's no cure, but there are a number of effective treatments you can discuss with a ...